Navigation Links
Ambiguous results in screening for celiac disease among young people
Date:11/15/2013

Most children who undergo screening to detect gluten intolerance, celiac disease, can handle it well. However, many people feel that the discovery of the disease and the treatment they receive does not provide a better quality of life. Katrina Nordyke will address this topic as she defends her PhD thesis at Ume University on November 15.

Celiac disease is a chronic disease attributable to genetic susceptibility which causes damage to the small intestine by the intake of gluten in the diet. It is estimated that between 1 and 3 percent of the population have the disease, but the number of unreported cases is high and most sufferers go undiagnosed. Sweden has higher rates of coeliac disease than the rest of the western world.

The benefits of screening for celiac disease in the general population is controversial and the consequences of being diagnosed when screening has been unclear. Sweden has had an epidemic of celiac disease. Therefore, researchers at Ume University conducted the population-based research project ETICS, Exploring the Iceberg of Celiacs in Sweden, to investigate issues arising with celiac disease and screening for the disease. All sixth graders in five regions in Sweden were invited to participate in the study during 2005/2006 and 2009/2010.

In her thesis, Katrina Nordyke examines the experiences and results of screening to detect celiac disease in these children. She notes that the results are ambiguous.

"Most kids can handle the concerns of the screening examination and thoughts about the disease may present. However, there was no consensus that the detection of disease and treatment results in an increased health-related quality of life.", says Katrina Nordyke.

The children involved in ETICS wrote short stories where they described their screening experience before they received their screening results. The stories show that some children experienced the fear and anxiety, but as a whole they managed the screening well. The kids also filled out surveys about their health-related quality of life at the time of the screening and one year after diagnosis. Finally, those who received a celiac diagnosis from the screening wrote new stories one and five years after diagnosis.

According to Katrina Nordyke, the stories show that the threat from complications caused by the disease affected how young people experienced the diagnosis, how they coped with the gluten-free diet and what they thought of screening for celiac disease.

"Five years after diagnosis of celiac disease, the majority of young people have learned to live with the disease, and acquired habits and strategies to cope with living with gluten-free diet. But at the same time some of these young people still doubt the benefits of having been diagnosed with celiac disease through the screening", says Katrina Nordyke.

Katrina Nordyke comes from the United States where she worked as a nurse. Today, she lives in Ume, where she received a Masters Degree in Public Health and is a PhD student at the Department of Public Health and Clinical Medicine, Ume University.


'/>"/>

Contact: Katrina Nordyke
katrina.nordyke@epiph.umu.se
46-709-622-688
Umea University
Source:Eurekalert

Related medicine news :

1. Study finds that Americans want doctors guidance on genetic test results
2. SweetCheeks Products Goes ‘Thigh Tech’ with First Anti-Cellulite Mat with Immediate Results for at Home Use
3. Congenital blindness results in lower thermal pain thresholds
4. Experimental drug shows encouraging results in treating most common form of lung cancer
5. Results of the GIANT trial reported at TCT 2013
6. Targeted Medical Pharma Reports Initial Results From a Clinical Observation of Medical Foods for Autistic Spectrum Disorder Symptoms
7. Results of the OPTIMIZE trial presented at TCT 2013
8. Results of the ARCTIC-INTERRUPTION trial presented at TCT 2013
9. Results of DUTCH PEERS (TWENTE II) trial reported at TCT 2013
10. HIPAA Crackdown Results in Expansion of Secure Texting Solution for Physicians
11. Results of the COREVALVE EXTREME RISK trial presented at TCT 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... of two biometric time and attendance tracking products: the new NCheck Cloud Bio ... Cloud Bio Attendance uses biometric face recognition to enable users to check in ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... , ... A minimally invasive porcelain veneer is increasing in ... of Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive ... laboratories and technicians that create these veneers. , According to National Board ...
(Date:3/28/2017)... Kennett Square, PA (PRWEB) , ... March 28, 2017 , ... ... reputation online and across a variety of business channels. , While many results ... aspects of any public relations program. , When it comes to measurement, firms ...
(Date:3/28/2017)... ... 2017 , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader ... women’s hair loss. Although hair transplant procedures can be seen as more of a ... can be two reasons a woman may see her hair thinning. , “We are ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), a ... serious pulmonary diseases, today announced that it has added two ... and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the Pediatric ... Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017 ... to reach USD 16.0 billion by 2025, according to ... growing prevalence of chronic diseases is anticipated to be ... analyzers, which thereby widens the scope for growth during ... and bariatric population, which is highly susceptible to chronic ...
(Date:3/27/2017)... BOSTON , March 27, 2017  Allergan ... and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical ... innovative therapies based upon tetracycline chemistry, announced that ... the treatment of moderate to severe acne met ... a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with ...
Breaking Medicine Technology: